Fulcrum Therapeutics Inc. August 22, 2023 - by Joey Ramson $FULC is up around 45% at the moment and sitting right at its 200DMA, after the FDA announced that it was lifting a hold on the company’s sickle-cell disease drug FTX-6058 Share this article:
